Following the footsteps of AstraZeneca, Pfizer-BioNtech has 92% effectiveness after two jabs, per Reuters.
However, Bloomberg cites 22.7% American having no plans to get vaccinated.
Following the footsteps of AstraZeneca, Pfizer-BioNtech has 92% effectiveness after two jabs, per Reuters.
However, Bloomberg cites 22.7% American having no plans to get vaccinated.